Potential therapeutic properties of 32 for RA therapy seem to be related to the reduction of M1 polarization and secretion of inflammatory cytokines, while overexpressing M2 and IL-10 levels to alleviate inflammation and repair bone tissue in CIA mice. This evidence concerns the gene IL10 and rheumatoid arthritis.